Don Taylor is Executive Director, Licensing for The Ohio State University. Formerly, he served as Assistant Vice Chancellor for Health Sciences Translation, Executive Director of sciVelo and Associate Professor of Biomedical Informatics at the University of Pittsburgh, which included responsibilities for working across the six health sciences schools to advance the commercial translation of Pitt’s discoveries and inventions.
A 5-time life sciences entrepreneur, Dr. Taylor previously served as vice president of corporate development for Cellumen Inc., a bio-tools company, and for its spin-off company, Cernostics Inc., a cancer molecular diagnostics company. Prior to these positions, Dr. Taylor was the global pharmaceutical and biotechnology market segment manager for Thermo Fisher Scientific Inc., where he led product marketing campaigns involving a sales team of more than 500 people and $400 million in revenue. Prior to Thermo Fisher, Dr. Taylor served in a life sciences business development role with an artificial intelligence company (Vivisimo) that was later acquired by IBM as part of their big data platform expansion. He has served on the board of directors of several biotechnology companies and spent 6 years in life sciences economic development as an Executive in Residence with the Pittsburgh Life Sciences Greenhouse.
Dr. Taylor received his BS in information systems from Carnegie Mellon University and his MS and PhD degrees in bioengineering from the Swanson School of Engineering at the University of Pittsburgh. He earned an MBA at Pitt’s Katz Graduate School of Business and conducted postdoctoral research in pathology at Pitt’s School of Medicine where he became co-inventor on a stem-cell based therapeutic based on his wound healing and cancer research.